JP2008169193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008169193A5 JP2008169193A5 JP2007112535A JP2007112535A JP2008169193A5 JP 2008169193 A5 JP2008169193 A5 JP 2008169193A5 JP 2007112535 A JP2007112535 A JP 2007112535A JP 2007112535 A JP2007112535 A JP 2007112535A JP 2008169193 A5 JP2008169193 A5 JP 2008169193A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antihistamine
- azelastine
- phenylpropionic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- XMIIGOLPHOKFCH-UHFFFAOYSA-N Phenylpropanoic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims 4
- 230000001387 anti-histamine Effects 0.000 claims 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims 4
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 4
- 239000000739 antihistaminic agent Substances 0.000 claims 4
- 239000003907 antipyretic analgesic agent Substances 0.000 claims 4
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 claims 3
- 210000002175 Goblet Cells Anatomy 0.000 claims 3
- 206010020718 Hyperplasia Diseases 0.000 claims 3
- 229960004574 azelastine Drugs 0.000 claims 3
- 230000001629 suppression Effects 0.000 claims 3
- 206010006451 Bronchitis Diseases 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 claims 2
- HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- 229960002373 loxoprofen Drugs 0.000 claims 2
- WORCCYVLMMTGFR-UHFFFAOYSA-M loxoprofen sodium Chemical compound [Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 WORCCYVLMMTGFR-UHFFFAOYSA-M 0.000 claims 2
- 229960005042 mequitazine Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- MUXFZBHBYYYLTH-UHFFFAOYSA-N 2-(6-oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid Chemical compound O=C1CC2=CC(C(C(O)=O)C)=CC=C2SC2=CC=CC=C21 MUXFZBHBYYYLTH-UHFFFAOYSA-N 0.000 claims 1
- 229960004335 Azelastine hydrochloride Drugs 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 208000007451 Chronic Bronchitis Diseases 0.000 claims 1
- YNNUSGIPVFPVBX-NHCUHLMSSA-N Clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 claims 1
- 229960002689 Clemastine Fumarate Drugs 0.000 claims 1
- 206010011224 Cough Diseases 0.000 claims 1
- 229960005341 Fenoprofen Calcium Drugs 0.000 claims 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 1
- 229960003630 Ketotifen Fumarate Drugs 0.000 claims 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N Oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 claims 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 206010057190 Respiratory tract infection Diseases 0.000 claims 1
- 229950004227 Zaltoprofen Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001154 acute Effects 0.000 claims 1
- YEJAJYAHJQIWNU-UHFFFAOYSA-N azelastine hydrochloride Chemical compound Cl.C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 YEJAJYAHJQIWNU-UHFFFAOYSA-N 0.000 claims 1
- VHUXSAWXWSTUOD-UHFFFAOYSA-L calcium;2-(3-phenoxyphenyl)propanoate Chemical compound [Ca+2].[O-]C(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1.[O-]C(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 VHUXSAWXWSTUOD-UHFFFAOYSA-L 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 229960002881 clemastine Drugs 0.000 claims 1
- PMGQWSIVQFOFOQ-YKVZVUFRSA-N clemastine fumarate Chemical compound OC(=O)\C=C\C(O)=O.CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PMGQWSIVQFOFOQ-YKVZVUFRSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229960002390 flurbiprofen Drugs 0.000 claims 1
- 229960004958 ketotifen Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960002739 oxaprozin Drugs 0.000 claims 1
- 229960003101 pranoprofen Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007112535A JP5094197B2 (ja) | 2006-04-27 | 2007-04-23 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006124023 | 2006-04-27 | ||
| JP2006124023 | 2006-04-27 | ||
| JP2006274659 | 2006-10-06 | ||
| JP2006274659 | 2006-10-06 | ||
| JP2006334040 | 2006-12-12 | ||
| JP2006334040 | 2006-12-12 | ||
| JP2007112535A JP5094197B2 (ja) | 2006-04-27 | 2007-04-23 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012177589A Division JP2012214512A (ja) | 2006-04-27 | 2012-08-09 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物２ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008169193A JP2008169193A (ja) | 2008-07-24 |
| JP2008169193A5 true JP2008169193A5 (fr) | 2010-05-13 |
| JP5094197B2 JP5094197B2 (ja) | 2012-12-12 |
Family
ID=39697634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007112535A Active JP5094197B2 (ja) | 2006-04-27 | 2007-04-23 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 |
| JP2012177589A Pending JP2012214512A (ja) | 2006-04-27 | 2012-08-09 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物２ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012177589A Pending JP2012214512A (ja) | 2006-04-27 | 2012-08-09 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物２ |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP5094197B2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010111666A (ja) * | 2008-10-10 | 2010-05-20 | Daiichi Sankyo Healthcare Co Ltd | セチリジンを含有する鎮咳及び／又は去痰のための医薬組成物 |
| JP5624367B2 (ja) * | 2009-05-28 | 2014-11-12 | 興和株式会社 | ロキソプロフェン含有医薬製剤 |
| NZ712180A (en) | 2013-03-13 | 2017-01-27 | Flatley Discovery Lab Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0277352B1 (fr) * | 1987-01-17 | 1991-10-16 | ASTA Pharma Aktiengesellschaft | Association synergétique d'azélastine et de théophylline ou d'azélastine et de bêta-mimétiques |
| DE69229070T2 (de) * | 1991-02-09 | 1999-11-18 | B.S.D. Bio Science Development Snc Di Omini C. & Zuccari G., Bussero | Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation |
| JP2004210800A (ja) * | 1996-05-22 | 2004-07-29 | Taisho Pharmaceut Co Ltd | 鎮咳剤 |
| JP4357016B2 (ja) * | 1998-11-06 | 2009-11-04 | 第一三共株式会社 | ロキソプロフェンを含有する医薬組成物 |
| JP2002332229A (ja) * | 2001-03-06 | 2002-11-22 | Taisho Pharmaceut Co Ltd | 感冒用組成物 |
| JP4614638B2 (ja) * | 2002-06-07 | 2011-01-19 | 第一三共株式会社 | 鎮痛剤組成物 |
| JP4614640B2 (ja) * | 2002-07-04 | 2011-01-19 | 第一三共株式会社 | 解熱剤組成物 |
| JP2005289906A (ja) * | 2004-03-31 | 2005-10-20 | Zeria Pharmaceut Co Ltd | 医薬組成物 |
| JP2005289905A (ja) * | 2004-03-31 | 2005-10-20 | Zeria Pharmaceut Co Ltd | 医薬組成物 |
| JP2005289904A (ja) * | 2004-03-31 | 2005-10-20 | Zeria Pharmaceut Co Ltd | 医薬組成物 |
| JP4710240B2 (ja) * | 2004-03-31 | 2011-06-29 | ゼリア新薬工業株式会社 | 医薬組成物 |
| JP2005289903A (ja) * | 2004-03-31 | 2005-10-20 | Zeria Pharmaceut Co Ltd | 医薬組成物 |
| ES2704482T3 (es) * | 2004-11-24 | 2019-03-18 | Meda Pharmaceuticals Inc | Composiciones que comprenden azelastina y sus métodos de uso |
| JP4832045B2 (ja) * | 2005-09-28 | 2011-12-07 | ロート製薬株式会社 | メキタジン、イブプロフェン及びトラネキサム酸含有医薬組成物 |
-
2007
- 2007-04-23 JP JP2007112535A patent/JP5094197B2/ja active Active
-
2012
- 2012-08-09 JP JP2012177589A patent/JP2012214512A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2611483T3 (es) | Agente terapéutico para enfermedad inflamatoria intestinal | |
| ES2530719T3 (es) | Formulaciones de oxicodona para ser administradas una vez al día | |
| JP2011522816A5 (fr) | ||
| JP2012520883A5 (fr) | ||
| ES2525495T1 (es) | Composición farmacéutica de liberación controlada que comprende éster de ácido fumárico | |
| JP2009500045A5 (fr) | ||
| JP2006518387A5 (fr) | ||
| JP2009541443A5 (fr) | ||
| RU2015117267A (ru) | Замещенные соединения амида | |
| JP2005517669A5 (fr) | ||
| HRP20180942T1 (hr) | Liječenje negativnih simptoma shizofrenije s (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamidom i njegovim farmaceutski prihvatljivim solima | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| JP2007314517A5 (fr) | ||
| JP2008516909A5 (fr) | ||
| JP2007314517A (ja) | ロキソプロフェンを含有する鎮咳又は去痰のための医薬組成物 | |
| JP2011527333A5 (fr) | ||
| JP2009280621A5 (fr) | ||
| AR056063A1 (es) | Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento de trastornos del sueno en el paciente deprimido | |
| RU2007132725A (ru) | Применение неопиатного анальгетика флупиртина для лечения гиперактивности мочевого пузыря и родственных заболеваний, в том числе неотложного недержания мочи, проблем с мочеотделением, как результата гиперплазии предстательной железы и синдрома раздраженного кишечника | |
| JP2021073257A5 (fr) | ||
| NZ595376A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| JP2008013542A (ja) | 去痰又は気道杯細胞過形成抑制のための医薬組成物 | |
| JP2020529995A5 (fr) |